Search results
Cancer disappears in 100% of patients treated with new drug in promising clinical trial
Euronews via Yahoo News· 5 days agoA study showed a 100 per cent positive response rate in 42 patients with a specific type of rectal ...
Scientists find new major cause of inflammatory bowel disease
MedicalNewsToday via AOL· 4 days agoScientists have identified a new genetic mechanism that drives the development of inflammatory bowel...
Stoma-friendly facilities added to St Helier public toilet
BBC News· 15 hours agoFacilities to help people with stomas have been introduced at a toilet in a town hall. The Parish of...
AbbVie and FutureGen Announce License Agreement to Develop Next-Generation Therapy for Inflammatory ...
The Port Lavaca Wave· 4 days ago- Global license agreement to focus on the development of FG-M701, a TL1A antibody, for the treatment of inflammatory bowel disease (IBD)
Jaguar Health to Report Pivotal Phase 3 OnTarget Trial Results for its Cancer Supportive Care Drug...
San Mateo Daily Journal· 5 days agoInvestor webcast on or before July 23 will include updates on Jaguar's cancer supportive care...
2024 Warren Alpert Foundation Prize Honors Four Pi | Newswise
Newswise· 7 days agoThe 2024 Warren Alpert Foundation Prize has been awarded to four scientists whose transformational discoveries led to the creation of chimeric antigen receptor (CAR) T cells, a treatment ...
Amy Dowden gets MBE as King's Birthday Honours list is revealed
BBC News· 3 days agoThe Strictly star has been made a Member of the Order of the British Empire (MBE) for her services...
Early-Onset CRC Does Not Require More Intense Surveillance
Medscape· 15 hours agoPatients with early-onset CRC did not have a greater risk for advanced polyps than their average-onset counterparts, calling into question their need for increased surveillance.
Debulking Does Not Improve Survival in Multiorgan Mets CRC
Medscape· 7 days agoInvestigators found that tumor debulking in multiorgan metastatic colorectal cancer will not extend...
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
Zacks via Yahoo Finance· 3 days agoThe FDA accepted AstraZeneca’s supplemental new drug application (sNDA), seeking expanded use of...